Prostate epithelium-derived Ets transcription factor mRNA is overexpressed in human breast tumors and is a candidate breast tumor marker and a breast tumor antigen.
about
Prostate-derived Ets transcription factor (PDEF) is a potential prognostic marker in patients with prostate cancerNovel role for PDEF in epithelial cell migration and invasionIdentification and confirmation of a module of coexpressed genesIdentification of MGB1 as a marker in the differential diagnosis of lung tumors in patients with a history of breast cancer by analysis of publicly available SAGE dataGlobal gene expression analysis identifies PDEF transcriptional networks regulating cell migration during cancer progressionBioinformatic screening of human ESTs for differentially expressed genes in normal and tumor tissues.Prostate-derived Ets transcription factor (PDEF) downregulates survivin expression and inhibits breast cancer cell growth in vitro and xenograft tumor formation in vivo.Prostate-derived Ets transcription factor as a favorable prognostic marker in ovarian cancer patients.Transcriptional regulation of p21/CIP1 cell cycle inhibitor by PDEF controls cell proliferation and mammary tumor progression.Ets-1 global gene expression profile reveals associations with metabolism and oxidative stress in ovarian and breast cancersProstate-Derived ETS Factor Regulates Epithelial-to-Mesenchymal Transition through Both SLUG-Dependent and Independent MechanismsRelative mRNA expression of prostate-derived E-twenty-six factor and E-twenty-six variant 4 transcription factors, and of uridine phosphorylase-1 and thymidine phosphorylase enzymes, in benign and malignant prostatic tissue.Identification and characterization of optimal gene expression markers for detection of breast cancer metastasisThe endoplasmic reticulum stress transducer OASIS is involved in the terminal differentiation of goblet cells in the large intestine.Lunx is a superior molecular marker for detection of non-small cell lung cancer in peripheral blood [corrected]Gene expression of circulating tumour cells in breast cancer patientsProstate-derived Ets transcription factor overexpression is associated with nodal metastasis and hormone receptor positivity in invasive breast cancerThe transcription factor SPDEF suppresses prostate tumor metastasisExpression characteristics of prostate-derived Ets factor support a role in breast and prostate cancer progression.PDEF promotes luminal differentiation and acts as a survival factor for ER-positive breast cancer cells.Prostate derived Ets transcription factor and Carcinoembryonic antigen related cell adhesion molecule 6 constitute a highly active oncogenic axis in breast cancer.Increased expression of EHF via gene amplification contributes to the activation of HER family signaling and associates with poor survival in gastric cancer.Gene expression markers in circulating tumor cells may predict bone metastasis and response to hormonal treatment in breast cancer.Loss of PDEF, a prostate-derived Ets factor is associated with aggressive phenotype of prostate cancer: regulation of MMP 9 by PDEF.Prostate-derived ETS factor improves prognosis and represses proliferation and invasion in hepatocellular carcinoma.Gene signature driving invasive mucinous adenocarcinoma of the lung.AR-PDEF pathway promotes tumour proliferation and upregulates MYC-mediated gene transcription by promoting MAD1 degradation in ER-negative breast cancer
P2860
Q24306191-8786EF20-0F23-4107-A4C9-DFE1AC1A3558Q24633487-91F50420-9A3C-4F6C-92FB-9F20863C3A1AQ24682475-16739581-D4DC-4801-AB06-31D4E43A69D0Q24685936-05803F58-AD14-49F7-B2F0-742C2D1C4349Q30157655-EE65CD75-64AB-4CA9-A9E8-3C7AD8B52B8FQ33241205-17616CB1-960A-4085-8D82-65C3C90F1358Q33652494-3C29BC8D-4592-4CAF-8B11-71BDF46D10D3Q33681985-FF97BA42-6335-42DA-8E5F-0B457FD576ACQ33799676-2DCF8C5F-E75B-479B-94D8-5798DA3EDE9CQ34258968-19EA9D3C-BFD3-4904-A089-95CDABAD7E92Q35034883-12FD1C3C-DE47-47ED-BC02-E44294403B71Q35758944-60399A44-BD4A-44E2-8F7B-63CD9016A973Q35789997-E94C0D84-172A-49BC-9936-E51316F7A6D4Q35868198-75ACF19E-70BA-4527-9226-080946167507Q35870328-BB79EA43-5B5C-4B2F-93A5-7D2CF22D09D0Q35960074-8D9C53CD-6053-44B7-A7EE-535FDC3A1A58Q36088622-6734936F-9670-4F04-BD3C-916448195178Q36215965-1BD347A6-8C64-4D3F-83E6-21E97766D065Q36238784-C6EBE849-FF17-4616-8AE8-1577B85EEEC7Q37011750-862C67F8-0273-4E1D-B264-B862C0D9F9E5Q37038409-CDD84CAC-558B-4C7C-8364-626EDFC8A0F6Q37465999-BE52A6F4-FF67-48E1-86F5-4B22B473B138Q37560932-E916097F-E641-4125-B003-A6723D7F4E66Q39692770-7B8435F6-2CD1-41CA-BF29-6807EABF637FQ41592766-AF0B874E-4AB6-420B-AED1-B06EC2F7B7ECQ42293061-22AA3B42-5905-4854-A4CE-DC23231AEAE6Q58740515-89878929-CEB1-4C28-AD3D-4A6007F7425F
P2860
Prostate epithelium-derived Ets transcription factor mRNA is overexpressed in human breast tumors and is a candidate breast tumor marker and a breast tumor antigen.
description
2001 nî lūn-bûn
@nan
2001 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Prostate epithelium-derived Et ...... er and a breast tumor antigen.
@ast
Prostate epithelium-derived Et ...... er and a breast tumor antigen.
@en
type
label
Prostate epithelium-derived Et ...... er and a breast tumor antigen.
@ast
Prostate epithelium-derived Et ...... er and a breast tumor antigen.
@en
prefLabel
Prostate epithelium-derived Et ...... er and a breast tumor antigen.
@ast
Prostate epithelium-derived Et ...... er and a breast tumor antigen.
@en
P1476
Prostate epithelium-derived Et ...... ker and a breast tumor antigen
@en
P2093
P304
P407
P577
2001-09-01T00:00:00Z